Australian Government: Australian Institute of Health and Welfare METeOR Home Page

Pharmaceutical Benefits Scheme (PBS) prescription—therapeutic group, code N

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termTherapeutic group
METeOR identifier:Help on this term605587
Registration status:Help on this termCommonwealth Department of Health, Standard 17/12/2015
Definition:Help on this term

A narrowly defined group of drugs listed in the Schedule of Pharmaceutical Benefits that are of similar safety and efficacy and provide similar health outcomes, as represented by a code.

Context:Help on this term

Therapeutic groups are defined for the purpose of comparative pricing. The government subsidises all drugs within a therapeutic group up to the level of the lowest priced drug. Any difference between the subsidised price and the price of the drug used by the patient is called the 'therapeutic group premium' and is paid by the patient.

Data Element Concept:Pharmaceutical Benefits Scheme (PBS) prescription—therapeutic group

Value domain attributes

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termNumber
Format:Help on this termN
Maximum character length:Help on this term1
Permissible values:Help on this term
ValueMeaning
1ACE inhibitor group
2ATRA group
4H2RA group
5PPI group
7Statins-HP group
8Venlafaxine group
Supplementary values:Help on this term
0Item does not belong to a therapeutic group

Collection and usage attributes

Guide for use:Help on this term

Due to the number of changes to the lists of drugs included in the various therapeutic groups, this value domain is only suitable for use in relation to data for part or all of the 2013-14 financial year.

The Permissible values in this value domain equate to Part numbers in the relevant Determination describing each therapeutic group and the drugs included in each therapeutic group, i.e. the National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010 (PB 1 of 2010) (Cwth).

CODE 1   Angiotensin converting enzyme (ACE) inhibitor group

This group includes the following listed drugs:

  • Fosinopril

NOTE: This therapeutic group was removed from the therapeutic groups listed in the Determination by amendment PB 47 of 2013, effective from 1 August 2013. 

CODE 2   Angiotensin II receptor antagonist (ATRA) group

This group includes the following listed drugs:

  • Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Valsartan

CODE 4   H2 receptor antagonist (H2RA) group

This group includes the following listed drugs:

  • Nizatidine

CODE 5   Proton pump inhibitor (PPI) group

This group includes the following listed drugs:

  • Esomeprazole, Rabeprazole

NOTE: Rabeprazole was removed from this therapeutic group, as listed in the Determination, by amendment PB 23 of 2014, effective from 1 April 2014.

CODE 7   Statins-HP group

This group includes the following listed drugs:

  • Atorvastatin, Rosuvastatin

NOTE: Atorvastatin was removed from this therapeutic group, as listed in the Determination, by amendment PB 77 of 2013, effective from 1 December 2013.

CODE 8   Venlafaxine group

This group includes the following listed drugs:

  • Desvenlafaxine, Venlafaxine

NOTE: Venlafaxine was removed from this therapeutic group, as listed in the Determination, by amendment PB 77 of 2013, effective from 1 December 2013.

Comments:Help on this termThis value domain retains the relevant permissible values, i.e. Part numbers from within the Determination, from previous versions to ensure consistency across versions.

Source and reference attributes

Submitting organisation:Help on this termDepartment of Health
Reference documents:Help on this term

Office of Parliamentary Counsel, ComLaw website 2013. National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010 (PB 1 of 2010), including amendments up to PB 6 and 7 of 2013. Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2013C00269

Office of Parliamentary Counsel, ComLaw website 2013. National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 3) (PB No. 47 2013). Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2013L01455

Office of Parliamentary Counsel, ComLaw website 2013. National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010 (PB 1 of 2010), including amendments up to PB 47 of 2013. Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2013C00559

Office of Parliamentary Counsel, ComLaw website 2013. National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 4) (PB No. 77 2013). Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2013L02010

Office of Parliamentary Counsel, ComLaw website 2013. National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010 (PB 1 of 2010), including amendments up to PB 77 of 2013. Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2013C00954

Office of Parliamentary Counsel, ComLaw website 2014. National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2014 (No. 1) (PB No. 23 2014). Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2014L00359

Office of Parliamentary Counsel, ComLaw website 2014. National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010 (PB 1 of 2010), including amendments up to PB 23 of 2014. Office of Parliamentary Counsel, Canberra. Viewed 17 November 2015,
https://www.comlaw.gov.au/Details/F2014C00292

Data element attributes

Collection and usage attributes

Guide for use:Help on this term

Drugs listed within a therapeutic group are therapeutically interchangeable with other drugs in the same group.

Source and reference attributes

Submitting organisation:Help on this termDepartment of Health

Relational attributes

Implementation in Data Set Specifications:Help on this term

Pharmaceutical Benefits Scheme (PBS) state/territory data extract 2013-14 Commonwealth Department of Health, Standard 17/12/2015

DSS specific attributes +
My items Help on this term
Download Help on this term